Clinical Trial

Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to determine which type of medication, sufentanil or methadone, is better at controlling pain during and, more importantly, after surgery in patients undergoing a head and neck dissection with free flap or rotational tissue reconstruction. Prior to their operation, subjects will be randomized to receive either Sufentanil or Methadone. After surgery, research staff will obtain information about recovery and pain levels.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-01-15; most recent amendment 2026-04-27.
Trial Details
NCT Number NCT06784999
Lead Sponsor Indiana University
Conditions Free Flap Reconstruction
Enrollment 128 participants
Start Date 2025-01-10
Primary Completion 2027-11-04 (estimated)
Study Completion 2027-11-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-01